Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
about
New and emerging disease modifying therapies for multiple sclerosisThe T-cell pool is anergized in patients with multiple sclerosis in remissionT-cell regulation by CD46 and its relevance in multiple sclerosisHuman T regulatory cell therapy: take a billion or so and call me in the morningTranslating Treg Therapy in Humanized MiceFOXP3(+) Treg Cells and Gender Bias in Autoimmune DiseasesRegulatory T cells in autoimmune neuroinflammationThe aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune responseMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseCirculating immune cells in multiple sclerosis.Glutamate, T cells and multiple sclerosis.Effects of natalizumab treatment on Foxp3+ T regulatory cells.Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosisRegulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisHuman regulatory T cells in autoimmune diseasesThe contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisNeuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosisMechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseasesGut microbiome and the risk factors in central nervous system autoimmunity.FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking.Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisDual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.Multiple sclerosis: pathogenesis and treatment.CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers gameNonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6.Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosisInduction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences.CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
P2860
Q22242305-F19037E5-4D83-42AF-9F62-D2F0B8EB404FQ24643433-5F695362-69A0-496B-8C1B-63F70C615F71Q24653362-112FBB5C-2B50-40E1-8CED-6631FBDDB070Q24656069-19427D3A-93EB-4C6E-BCEA-C294A1CA494BQ26772335-ACD9ED9E-AFC4-4694-A299-C165B1B364EEQ26781235-05BC186C-FB7C-445A-B64C-65FD980377CAQ26825063-55AE6086-A04E-4BD9-B621-6BC037773048Q26991621-10C92EEC-4CA1-4425-96C0-0B24F0929019Q27011014-2BDD0841-D245-42F2-B544-1CB09E9EC584Q28080791-9ABA8DF2-E95D-407C-A930-1859DAD15AB1Q28081150-54A91D01-197C-408C-A02D-56287E5D6C9AQ30242026-A7B3C7CD-38EE-4082-8C3F-180A4FCB6F25Q31165986-B85BA690-BA9E-427A-8990-B3112307FCD0Q33373995-A0855520-C1B2-4205-A167-955414F8B62CQ33493067-1B04A2B2-AF22-408C-B833-D80BC02955B2Q33650505-46255260-B8A3-42B9-A45C-68E506488739Q33713942-75A441F2-43A0-46E7-A87C-9E9AEB35B116Q33729446-5059B6F0-0DB3-456F-9C40-FB758D0A72A1Q34384366-1F6BFFFA-BB97-45DE-97E0-A1868BFED86DQ34413247-2A925850-25E8-42FE-BF4C-7834BAC2FCF4Q34612943-A60CF33E-743D-4D69-8EEB-B7D708F8334BQ34615216-79CD7CEF-556F-4B60-B27C-E5E7B47801C0Q34624054-B5CF8F12-AF5B-4AB5-910A-347720642124Q34643537-3B4947AB-03B6-40B6-9384-9271929C12E0Q34869657-A3332AA1-2EA1-4BE4-9647-5578D964AD59Q35025511-FA015BDF-0554-4B56-BE3E-5BB4F0859C3DQ35068792-DB750598-8041-4493-8509-E6F6D64902D4Q35127765-3C967A66-826C-4665-8628-C24A59DF7F46Q35151851-C63C9962-2C04-4485-8B17-2C931C61881DQ35178495-A8811480-0ECA-4635-B8F7-3207F55C45A2Q35595880-BDD3657D-6FB4-4C2C-B3B9-96C02990FF7CQ35606563-77BC4A4F-39B6-48F5-92D1-C73554E47814Q35625089-C02C9D60-F190-4686-A81B-B092323CBE34Q35742931-8F07A6AA-0D38-4D5C-AD2A-9D2466F309C1Q36059631-A8001582-B2BF-455D-94F7-8E413C2414DAQ36096881-AEA4C724-449C-4F02-9BF1-C5549BF5F7A8Q36112863-B9B348CB-E672-4E9C-835F-BFD3ABBBE358Q36171406-A6B4D71E-4F6B-442B-AE54-EA652E5ED15EQ36189566-CAC6A592-1AA3-48AC-A24F-175D81223A52Q36299378-A3AC978D-71A0-4709-86FB-ED476D6DF0BE
P2860
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Reduced suppressive effect of ...... ients with multiple sclerosis.
@en
Reduced suppressive effect of ...... ients with multiple sclerosis.
@nl
type
label
Reduced suppressive effect of ...... ients with multiple sclerosis.
@en
Reduced suppressive effect of ...... ients with multiple sclerosis.
@nl
prefLabel
Reduced suppressive effect of ...... ients with multiple sclerosis.
@en
Reduced suppressive effect of ...... ients with multiple sclerosis.
@nl
P2093
P921
P356
P1476
Reduced suppressive effect of ...... tients with multiple sclerosis
@en
P2093
Andrea Filser
Andrea Viehöver
Andreas Hug
Benedikt Fritzsching
Brigitte Fritz
Brigitte Storch-Hagenlocher
Brigitte Wildemann
Christine S Falk
Elisabeth Suri-Payer
Linda Milkova
P304
P356
10.1002/EJI.200526065
P407
P50
P577
2005-11-01T00:00:00Z